You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
Turn on more accessible mode
Turn off more accessible mode
Skip Ribbon Commands
Skip to main content
Turn off Animations
Turn on Animations
SharePoint
Sign In
Follow
It looks like your browser does not have JavaScript enabled. Please turn on JavaScript and try again.
Home
About
CRISM​
OCRINT
National Executive Committee
Events
Research Projects
COVID-19 Research Projects
OPTIMA
Section 56 Consultation
Follow-Up Study of Federal Inmates on Opioid Agonist Treatment in Ontario
Implementation Science Program
Naloxone Distribution
Detoxification and Withdrawal Management
Corrections Projects
Guidance Documents
Currently selected
COVID-19 Rapid Guidance
Opioid Use Disorder
Injectable OAT
Lower Risk Cannabis Use Guidelines
Demonstration Projects
Best Practice Document on Harm Reduction Programs for PWUD
Chronic Disease Self-management Experiences among Marginalized PWUD
Impacts of Overdose Study
It Takes a Village
Best Practices in Buprenorphine/Naloxone Initiation in Provincial Correctional Facilities
Asset Mapping of Substance Use Prevention and Intervention Programs and Services
Surviving Opioid Overdose with Naloxone Education and Resuscitation
Integrating Access to Anti-Craving Medications for Adult Women with SUD
Northern Ontario Drug Use and Service Needs Assessment (NODUS)
Youth Substance Use Service Provider Study
Identifying Service Needs among PWUD
Publications and Reports
Academic Journal Articles
Ontario Drug Use Compendium
Topic Summaries
Contact Us
Guidance Documents
Page Content
A core function of the Ontario CRISM node team (OCRINT) is to develop and collaborate on evidence-based guidelines and protocols focused on reducing substance use-related harms and informing health system interventions and related policies. To this end, OCRINT has engaged with the national CRISM team and key stakeholders to undertake a number of evidence-based guidance documents toward effective approaches to substance use screening, treatment, and interventions.
The following are a few of these key guidelines.